Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 05:13 PM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Penny Stock Picks » Buy: New Pain Treatment Triumphs Morphine (OTC:NPHC)

Thread Tools Search this Thread
Old 09-11-2009, 02:04 AM   Nav to Top  #1
Dog House
StocksHaven's Avatar
Join Date: May 2009
Location: Toronto
Posts: 37
Rep Power: 0
Reputation: -13
StocksHaven can only hope to improve
Devil New Pain Treatment Triumphs Morphine (OTC:NPHC)

Nutra Pharma Corp. - Nutra Pharma Corp. - Google Finance

(Public, OTC:NPHC.OB)

Step aside Morphine, the new king of chronic pain treatment has entered the building. With Nutra Pharma’s stock rising nearly 2300% year-to-date, its time we see what all the commotion is about. StocksHaven Investments takes a closer look at Nutra Pharma Corp., which believes will begin generating significant revenues within the next 12 months. The company has recently made waves throughout the biotech space with their recent “Best New Product” award winning drug, Cobroxin. The product is the first clinically proven treatment for stage 2 (moderate to severe) chronic pain, and was awarded the honour at the Efficient Collaborative Retail Marketing (ECRM) Conference in Miami, Florida. Winning this was no easy task, as a handful of well known companies attended the conference. The company is also developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS) through their wholly owned subsidiary, ReceptoPharm Inc. With billions of dollars in potential target markets, Nutra Pharma is one company which is ready to take the biopharmaceuticals sector by storm.


Nutra Pharma Corp. is a development-stage biopharmaceutical company engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases. The Company’s wholly owned subsidiary, ReceptoPharm, Inc. (Recepto Pharm) is a development stage biopharmaceutical company, which is engaged in developing technologies to treat the neurological diseases: multiple sclerosis; adrenomyeloneuropathy; amyotrophic lateral sclerosis; myasthenia gravis; and to treat the viral diseases, human immunodeficiency virus (HIV) and hepatitis-C. The Company’s other wholly owned subsidiary Designer Diagnostics, Inc. (Designer Diagnostics) is engaged in marketing diagnostic test kits that are used for the rapid identification of infectious human diseases, such as Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).

Midterm goal

Nutra Pharma Corp’s midterm strategy for the past three years has been to license Nutra Pharma Corp’s AMN, MS and HIV technologies in Nutra Pharma Corp’s attempt to bring these technologies to market within 5 years. Should Nutra Pharma Corp. obtain adequate financing, Nutra Pharma Corp’s midterm strategy remains the same— to accomplish these midterm goals in the next two years of that 5 year period.

Long-term goal

Nutra Pharma Corp’s long-term goal is the use of drugs developed by ReceptoPharm and future affiliates in the field of neurological diseases, infectious diseases and autoimmune disorders. Due to Nutra Pharma Corp’s limited financial and operational resources, this goal will require Nutra Pharma Corp. to establish strategic partners or alliances with pharmaceutical companies, academic institutions, biotechnology companies, and clinical diagnostic laboratories, which will: (a) complement Nutra Pharma Corp’s research and development efforts; (b) reduce the risks associated with undertaking the entire process of drug development and marketing; and (c) generate licensing based revenue streams.

Read full article at New Pain Treatment Triumphs Morphine (OTC:NPHC) |

Last edited by Miles; 09-11-2009 at 03:28 AM..
StocksHaven is offline   1 thumbs up / 2 thumbs down. Rate this post Yes | No Reply With Quote

Similar Threads
Thread Thread Starter Forum Replies Last Post
Strong Buy: Best Solar Stock on the OTC! solartrader US Penny Stock Picks 14 04-28-2011 06:05 PM
Spec: OTC:VSYM View System, Inc Insider US Penny Stock Picks 2 12-03-2009 09:28 AM
Strong Buy: Online Presentation: Breakthrough Treatment Of Pain (OTC:NPHC) StocksHaven US Penny Stock Picks 0 09-02-2009 01:34 AM
OTC: ADLS GreG US Penny Stock Picks 0 05-19-2009 12:11 AM
Buying OTC shares aim2high Traders Lounge 2 05-09-2009 06:31 AM

Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On